Tag: Labetuzumab

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Labetuzumab

Analysts Set Immunomedics, Inc. (IMMU) PT at $28.00

Added to Collection on: 2019-03-19 20:00:00

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Sectoral Asset Management Inc Raises Stake in Immunomedics, Inc. (NASDAQ:IMMU)

Added to Collection on: 2019-03-21 17:56:15

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Immunomedics (IMMU) Upgraded by BidaskClub to “Buy”

Added to Collection on: 2019-03-22 08:56:15

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
HC Wainwright Initiates Coverage on Immunomedics (IMMU)

Added to Collection on: 2019-03-26 07:26:15

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
16010 Shares in Immunomedics, Inc. (IMMU) Purchased by Mackenzie Financial Corp

Added to Collection on: 2019-03-28 10:37:30

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Immunomedics, Inc. (IMMU) Stake Increased by American International Group Inc.

Added to Collection on: 2019-03-29 19:32:27

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Immunomedics, Inc. (IMMU) Position Trimmed by Nuveen Asset Management LLC

Added to Collection on: 2019-03-31 01:03:45

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Nuveen Asset Management LLC Decreases Holdings in Immunomedics, Inc. (IMMU)

Added to Collection on: 2019-03-30 21:27:37

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
RA Capital Management LLC Sells 98312 Shares of Immunomedics, Inc. (IMMU)

Added to Collection on: 2019-04-02 15:52:30

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Immunomedics, Inc. (NASDAQ:IMMU) Receives Average Rating of "Buy" from Analysts

Added to Collection on: 2020-08-22 21:41:15

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Book a Demo